BioSpace News Archive

Business

Bionovelus Agrees to Co-Directorship and Advisory With Meroe Capital Group Ltd.

In the structure of the deal, BioNovelus will become a client of Meroe Capital’s prestigious “H2O Program II.”

November 14, 2017
·
4 min read
Business

Neovasc Announces Results for the Third Quarter of 2017

Revenues decreased 55% to $1,374,893 for the three months ended September 30, 2017, compared to revenues of $3,034,000 for the same period in 2016.

November 14, 2017
·
34 min read
Genetown

Hologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Senior Notes Due 2043

Hologic announced today that holders of the 2.00% Convertible Senior Notes due 2043 issued February 21, 2013 have the right to surrender their notes for repurchase by the Company.

November 14, 2017
·
4 min read
Business

Simulations Plus Reports FY2017 and Fourth Quarter FY2017 Financial Results

Earnings per share of $0.33, up 14.9% over prior year.

November 14, 2017
·
9 min read
Business

AmpliPhi Biosciences Reports Third Quarter 2017 Financial Results and Business Highlights

Cash and cash equivalents as of September 30, 2017 totaled $7.7 million.

November 14, 2017
·
10 min read
Business

DJO Global Announces Financial Results for Third Quarter 2017

Net sales grew 1.3% to $290.9 million, or 0.3% at constant currency rates.

November 14, 2017
·
21 min read
Bio NC

RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares

Gross proceeds from the sale of the ADSs by RedHill before underwriting discounts and commissions and other offering expenses were approximately $22.5 million.

November 14, 2017
·
7 min read
New Study Using Artificial Intelligence Shows Prevencio’s Simple Blood Test Accurately Detects Presence of Peripheral Artery Disease

Novel multi-protein test data with 98% accuracy presented at American Heart Association 2017 Scientific Sessions.

November 14, 2017
·
4 min read
Biotech Beach

Ligand Provides Highlights from Today’s Analyst Day Event - Nov. 15, 2017

The webcast is available at www.ligand.com.

November 14, 2017
·
16 min read
Business

Year-to-Date Gross Sales for Mytesi, the FDA-Approved Human Prescription Drug Product of Jaguar Health’s Wholly-Owned Subsidiary, Napo Pharmaceuticals, Total $2.8M

The average monthly Mytesi sales from August through October of this year increased over 50% relative to average monthly Mytesi® sales that took place from January through July of 2017.

November 14, 2017
·
8 min read